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IntroductIon
Immune memory is usually studied in the context of rein-
fection after clearance of an acutely infectious agent. At some 
point after the primary infection, the immune system returns 
to relative quiescence, but upon reinfection, there occurs a 
secondary or anamnestic response that is faster and more ro-
bust. This immunity arises as a result of increased precursor 
frequencies and functional changes in antigen-specific T and 
B cells and the presence of preformed specific antibodies. The 
long-lived antigen-specific T cells are retained in secondary 
lymphoid organs, in vascular circulation, and embedded in 
various organs as tissue-resident memory T cells (Masopust 
et al., 2001; Sallusto et al., 2004; Obar and Lefrançois, 2010; 
Steinert et al., 2015).
Many infectious agents have “adopted” persistence as a 
strategy to remain endemic within a host population. Such 
microbes and viruses are never completely cleared from the 
body, and thus, the immune system is indefinitely exposed 
to antigenic stimulation. As such, the notion of primary and 
secondary responses does not apply. Some examples of viral 
persistence are met with diminished T cell reactivity char-
acterized as exhaustion (Zajac et al., 1998; Day et al., 2006; 
Urbani et al., 2006; Wherry et al., 2007; Gigley et al., 2012; 
Barathan et al., 2015). Nonetheless, in all instances where 
this has been examined, such T cell populations play a con-
tinuing role in controlling the infectious agent (Zehn et al., 
2016). In other examples, such as the latency of α-, β-, or 
γ-herpesviruses, persistence is not associated with the typi-
cal characteristics of exhausted T cells, even though evidence 
shows that there is continuous antigenic stimulation (Klener-
man and Hill, 2005; Seckert et al., 2012).
The initial bias to form short-lived effector T cells 
versus long-lived memory T cells may occur as early as the 
first division of naive CD8+ T cells after antigen presentation 
(Chang et al., 2007). The daughter cell proximal to the an-
tigen-presenting cell expresses MYC, preferentially activates 
the mTOR pathway, and its progeny exhibit metabolic and 
functional characteristics of effector cells. The distal daugh-
ter cell is more likely to exhibit characteristics of memory T 
cells (Pollizzi et al., 2016; Verbist et al., 2016). Another arc of 
investigation has shown a role for FOXO1 in CD8+ T cell 
memory, where inactivation of the Foxo1 gene almost en-
tirely prevented a secondary memory response (Rao et al., 
2012; Hess Michelini et al., 2013; Kim et al., 2013). Because 
MYC can be antagonized by the transcription factor FOXO1 
or FOXO3 (Peck et al., 2013; Tan et al., 2015; Wilhelm et 
al., 2016), a proposal is that differential activity of FOXO1 
determines, in part, the initial outcome of effector versus 
memory specification (Verbist et al., 2016). Consistent with 
this notion, an analysis of T cells early in an infection showed 
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Figure 1. McMV-specific cd8+ t cell responses are compromised in Fx18Ko mice. (A) Model of bone marrow chimeras, tamoxifen treatment, and 
infection with MCMV-Δm157. (B) Accumulated data showing the course of T cell expansion and contraction over the course of infection. (c) Histograms 
represent the proportion in number of CD8+ T cells (IE3, M38, and M45) at 8, 41, and 69 dpi in the spleen. Data in B and C are cumulative from two experi-
ments for days 6 and 100, three experiments for days 8 and 21, and five experiments for day 41 and 69 with three to five mice per group and per time point 
for each experiment. (d) Viral titers were determined by plaque assay in the spleen and the liver at day 6 after infection. Data represent one experiment 
with four mice per group. (E) Histograms represent the number of tetramer+ T cells for each epitope in LNs, lungs, liver, and blood at day 41 after infection. 
Data are cumulative from two experiment with n = 4 mice per group and per experiment. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (unpaired 
Student’s t test); error bars represent mean ± SEM.
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that almost 90% of the gene expression specific to memory 
precursor cells was diminished in the absence of FOXO1 
(Hess Michelini et al., 2013). The importance of this finding 
is that FOXO transcription factors are dynamically regulated 
by many posttranslational modifications signaled by extrinsic 
input to the cell: the availability of growth factors and nutri-
ents or the presence of inflammation or oxidative stress (Cal-
nan and Brunet, 2008). Thus, a possibility is that the state of 
T cell differentiation itself is plastic and actively determined 
by the changing environment of a responding T cell.
In this study, we have investigated two issues related to 
T cell memory differentiation. First, within the diversity of 
long-lived T cells that arise as a result of a β-herpesvirus in-
fection, are there differential requirements for FOXO1 de-
pending on the kinetics and phenotypic characteristics of the 
responding T cells? Second, is the state of effector versus mem-
ory T cells permanently determined early in an infection, or 
must it be continuously maintained? Our studies reveal that 
T cell responses, defined by epitope recognition, were uni-
formly sensitive to the loss of FOXO1. With a loss of Foxo1, 
T cells expanded at a reduced rate, were deficient for effector 
cytokines, and exhibited characteristics of anergy. In addition, 
the results show that a memory phenotype must be actively 
maintained by the presence of FOXO1; upon inactivation of 
Foxo1, memory T cells reverted to a state reminiscent of ter-
minally differentiated effector T cells. The analysis provides a 
unique window into T cell differentiation and the complex 
interplay between short-lived effector T cells and long-term 
memory that develops in the presence of sustained antigens.
rEsults
Foxo1 is required for antigen-specific t cell 
expansion in response to McMV
To study the role of FOXO1 in the response to murine cyto-
megalovirus (MCMV), we produced radiation chimeric mice 
that provided a means of acutely deleting Foxo1 in CD8+ T 
cells. Bone marrow from either Foxo1f/f ER-Cre+ (Fx18KO 
chimera) or Foxo1f/f ER-Cre− (Fx1WT chimera) mice was 
mixed with bone marrow from Cd8a−/− mice and used to 
repopulate Tcra−/− mice ablated by lethal irradiation. After 
treatment with tamoxifen, only the Foxo1−/− CD8+ (Fx18KO) 
T cells are not complemented by WT bone marrow cells 
(Fig. 1 A). We note that this differs from our previous experi-
mental model in which Foxo1 was not deleted until after the 
T cells became activated (Hess Michelini et al., 2013). Chi-
meras were inoculated with MCMV Δm157 that lacks the 
ligand recognized by Ly49H+ NK cells because we wanted to 
focus on the cytotoxic T cell response, and most inbred and 
outbred mouse strains lack Ly49H (Brown et al., 2001; Arase 
et al., 2002; Smith et al., 2002; Scalzo et al., 2005).
Using antigen-specific tetramer staining, we analyzed 
T cell populations that recognize three immunodominant 
MCMV epitopes displaying distinct expansion and contrac-
tion kinetics (Fig. S1 A; Munks et al., 2006). As previously 
described, T cells that recognized the IE3 epitope, termed in-
flationary, showed very modest initial expansion but accumu-
lated steadily over the course of 100 d. T cells that recognized 
M38 rapidly expanded over the first week but did not con-
tract until more than 69 d after infection. In contrast, T cells 
that recognized the M45 epitope displayed kinetics typical of 
an acute viral infection: rapid expansion over the first week 
followed by equally rapid contraction (Fig. 1 B).
Within the population of Fx18KO T cells, there was a 
three- to fourfold reduction in the number of accumulated 
T cells throughout the course of the experiment, and yet 
the unique kinetic profile for each of these responses was 
retained. FOXO1 was necessary for both the initial acute 
expansion exemplified by M45-specific T cells and the slow 
inflation exemplified by IE3-specific T cells with no effect on 
the profile of contraction (Fig. 1 B). This is also depicted by 
the changing contribution of epitope-specific T cells over the 
course of the response (Fig. 1 C), and similar kinetics were 
found for T cells in the liver (Fig. S1 B). In addition, we found 
no differences in the numbers of dendritic cells (DCs), total 
CD4+ T cells or regulatory T cells (T reg cells; Fig. S1 C), 
and remarkably, virtually all of these cells were FOXO1+ (not 
depicted). This indicates that WT DCs, B cells, and CD4+ T 
cells outcompeted the equivalent Foxo1−/− cells. In addition, 
this inactivation of Foxo1 in CD8+ T cells had a modest but 
significant effect on the initial viral load in both the spleen 
and liver at 6 d after infection (Fig. 1 D). The efficiency of 
Foxo1 inactivation was verified in all tetramer+ cells at day 8 
after infection and through the end of the experiments (day 
69 after infection; Fig. S1 D and not depicted). We further 
determined whether the loss FOXO1 affected the MCMV- 
specific CD8+ T cell response in other organs. At day 41 after 
infection, the numbers of Fx18KO T cells were reduced in 
lung, liver, and blood as well as lymph nodes (Fig. 1 E). Alto-
gether, these data show an important role of FOXO1 for the 
maximal expansion of MCMV-specific CD8+ T cells specific 
for different viral epitopes.
Foxo1 is required for ongoing cd8+ t cell survival
To examine the origin of the diminished populations of T 
cells, the proportion of cells in cell cycle was determined by 
the expression of Ki67, a nucleolar protein not expressed in 
Go quiescent cells (Gerdes et al., 1984; Kill, 1996). There was 
no difference in the proportion of Fx18KO versus Fx1WT T 
cells in cycle at early or late time points (Fig. 2 A), and this 
suggested that the deficiency in T cell accumulation may 
be caused by a loss of viability. Consistent with BCL2 as an 
important survival factor that is induced in memory T cells 
(Wojciechowski et al., 2007; Kurtulus et al., 2011), we found 
that Foxo1-null T cells specific for all three epitopes expressed 
substantially lower amounts of BCL2 compared with Fx1WT 
T cells in the spleen and liver (Fig. 2 B and Fig. S2, A and B).
To enumerate apoptotic T cells, tetramer+ cells were 
analyzed for cell-surface Annexin V binding (Fig. 2 C) and 
intracellular cleaved caspase-3 (Fig. 2 D). Both measures re-
vealed a large increase in apoptotic or potentially apoptotic 
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cells found in Fx18KO versus Fx1WT T cells starting at day 8 
and all time points hence (Fig. S2 C). Moreover, an increase 
of apoptotic cells in Fx18KO was also observed in the LNs and 
lung (Fig. S2, D and E). Even during the contraction phase of 
M45-specific T cells, FOXO1 was required for T cell viability. 
Although in some contexts it can cause apoptosis (Brunet et 
al., 1999), these data suggest that FOXO1 is required to sus-
tain the viability of Ag-specific CD8+ T cells at all phases of 
the response. Simplistically, an increased rate of death would 
be expected to cause a progressive decrease in the relative 
number of Fx1 cells; however, the ratio of WT:KO T cells 
remains constant, and thus there may be other homeostatic 
effects on the total number of T cells.
Foxo1-null t cells exhibit anergy, but not 
checkpoint-specific exhaustion
The functional capability of T cells strongly correlates with 
their ability to produce multiple cytokines, especially the ef-
Figure 2. McMV-specific Fx18Ko cd8+ t cells are more prone to apoptosis. (A–d) Fx1WT and Fx18KO splenocytes specific for each of the three tetra-
mers were recovered at various times and analyzed for the expression of cell-surface or intracellular molecules as indicated. (A) Histograms bar represent 
the percentage of Ki67+ per tetramer at different time point. (B) FACS histograms represent the expression of BCL2 at day 69 after infection. Quantifica-
tions of BCL2 MFI were plotted for each tetramer. (C and D) FACS dot plot represent the expression of Annexin V (C) and activated caspase-3 (D). Numbers 
represent the percentage of Annexin V+ and activated caspase-3+ T cells, respectively. Data are cumulative from two experiments for (A, B, and D) with 
n = 3 or 4 mice per group and one experiment for (C) with n = 3 or 4 mice per group. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (unpaired Student’s t test); error 
bars represent mean ± SEM.
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Figure 3. Inflationary Fx18Ko cd8+ t cells are deficient for effector cytokines and display an anergic state. (A) Splenocytes from Fx1WT and Fx18KO 
chimeras were harvested at different time points after infection, and total splenocytes were stimulated for 5 h with or without specific peptide. Bivariant 
analysis of IFNγ and TNF at 41 dpi gated on CD8+ CD44hi cells (left) and graphed for each time point (right). Numbers represent the percentage of IFNγ+ TNF−, 
IFNγ+ TNF+ or IFNγ− TNF+. (B) Histogram of tetramer expression and the MFI plotted for T cells specific for each epitope. Data in A and B are cumulative from 
3 experiments with n = 4 mice for each group per experiment and per time point. (c) Curves show ratio of Fluo-4 MFI and FuraRed MFI over time. At 30 s, 
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fector cytokines IFNγ and TNF (Wherry et al., 2003; Betts 
et al., 2006). Fx1WT or Fx18KO T cells from MCMV-infected 
chimeras were stimulated with either IE3 or M38 peptide, and 
examined for the coexpression of IFNγ and TNF. Whereas 
most of the cytokine-producing WT T cells produced both 
IFNγ and TNF, the total percentage of cytokine-producing 
Fx18KO T cells was diminished, and these cells were equally 
distributed between single and double cytokine production 
(Fig. 3 A, left). This diminution of double cytokine producing 
T cells was characteristic of T cells throughout the course of 
the response (Fig. 3 A, right; and Fig. S3 A), and it was also re-
flected in the intensity of IFNγ expression per cell (Fig. S3 B).
Unlike the response to chronic LCMV infection, infec-
tion with MCMV or other herpesviruses does not appear to 
cause the responding T cell populations to induce cell-surface 
molecules characteristic of negative feedback regulation 
often referred to as “exhaustion” (Day et al., 2006; Urbani 
et al., 2006). How these persistent and latent virus infections 
fundamentally differ is unclear, but we sought to determine 
whether the lack of FOXO1 would alter this phenotype. As 
depicted in Fig. S3 C, there was no indication that any of 
the receptors typical of exhaustion were expressed on T cells 
from either genotype. This included PD-1, LAG-3, TIM-3, 
and CTLA-4. However, we noticed that there was a consis-
tent decrease in tetramer binding in Fx18KO T cells (Fig. 3 B) 
without a concomitant decrease in CD3ε (not depicted). This 
lower receptor avidity for antigen-MHC binding has been 
found in anergic CD4+ T cells (Mallone et al., 2005; Maeda 
et al., 2014) and CD8+ T cells recently activated with antigen 
(Drake et al., 2005). The diminished tetramer binding was 
caused by TCR redistribution, but not changes in receptor 
affinity. Similarly, we find that the reduced tetramer binding 
does not reflect a difference in TCR affinity as measured by a 
M38 tetramer decay assay (Fig. S3 G).
To study the role of FOXO1 in the anergy induction, 
we produced mixed chimeric mice in which bone marrow 
cells from Foxo1f/f ER-Cre+ CD45.2 (Fx18KO 5.2 chimera) 
and C57BL/6 CD45.1/CD45.2 (Fx1WT 5.1/5.2 chimera) mice 
were used to repopulate C57BL/6 CD45.1 mice ablated by 
lethal irradiation. This model allowed us to study the behavior 
of the Foxo1-null CD8+ T cells in a competition with the 
WT CD8+ T cells (Fig. S3 D). We note, in this competitive 
model, the number of Fx18KO 5.2 MCMV-specific CD8+ T 
cells was again reduced over the time of infection for all three 
epitopes (not depicted).
A hallmark of T cell anergy is a loss of sensitivity to 
stimulation through the T cell antigen receptor complex as 
measured by proximal signaling (Dubois et al., 1998). The 
total antigen-reactive T cell populations from the spleen of 
chimeras with both Fx1WT 5.1/5.2 and Fx18KO 5.2 T cells were 
stimulated by cross-linking CD3ε and the release of free 
calcium was measured over time. As shown, the calcium 
release was attenuated in Fx18KO 5.2 T cells compared with 
Fx1WT 5.1/5.2 T cells (Fig. 3 C) in the same culture, and this atten-
uated signaling manifested in reduced proliferation (Fig. 3 D).
This signaling defect also correlated with a reduced ac-
tivation of NFAT1,2 (Fig. S3 E). In addition, the transcrip-
tion factor EGR2 and three E3 ligases, GRA IL, CBL-B, 
and ITCH, have been associated with anergy, and all four 
were increased in Fx18KO 5.2 T cells (Fig. 3, E and F; and Fig. 
S3 F; Jeon et al., 2004; Safford et al., 2005; Whiting et al., 
2011; Oh et al., 2015). Collectively, these data demonstrate 
that FOXO1 expression is required to prevent the induc-
tion of anergy in Ag-specific CD8+ T cells that arise in re-
sponse to MCMV infection.
transcriptional control is dysregulated 
in the absence of Foxo1
CD27 is a TNF-family receptor member that serves as a core-
ceptor for T cell activation, marks memory precursors, and 
specifically promotes the inflationary T cell expansion in re-
sponse to MCMV infection (Borst et al., 2005; Welten et al., 
2015). Analysis of Fx1WT T cells showed that bivariant plots 
of KLRG1 versus CD27 reveals that these two cell surface 
molecules are largely expressed on distinct subsets after infec-
tion. The inflationary T cells specific for IE3 or M38 predom-
inantly show characteristics of effector T cells, whereas the 
acutely reactive M45-specific T cells are more evenly divided 
between putative effector and memory-effector T cells. How-
ever, a loss of FOXO1 affects acute and inflationary T cells 
similarly at late time points, in each case exaggerating effector 
characteristics (Fig. 4, A and B). The use of CD27 to delineate 
a memory cell phenotype was further indicated by an analysis 
of ID3 expression, a characteristic of memory T cells (Yang 
et al., 2011; Fig. 4 C).
As a counterpart to ID3 in memory T cells, TBET 
(TBX21) is a key transcription factor in the induction of ef-
fector T cells (Rutishauser and Kaech, 2010), and previous 
work has shown that its down-regulation depends on the ex-
pression of FOXO1 (Kerdiles et al., 2010; Rao et al., 2012). 
anti–hamster antibody was added (arrow). The curves represent the CD8+ CD44hi CD11ahi T cells for Fx1WT 5.1/5.2 and Fx18KO 5.2 cells. Data are representative of 
two experiments with three mice each (n = 6; two mice shown). (d) Total CD8+ T cells from Fx1WT 5.1/5.2 chimeras and Fx18KO 5.2 chimeras were isolated from 
the spleen and activated for 3 d with plate-bound CD3- and CD28-specific antibodies. CFSE profiles are shown for CD8+ T cells gated on CD45.1+ CD45.2+ 
and CD45.2+ CD45.1− for Fx1WT 5.1/5.2 (black) and Fx18KO 5.2 (red), respectively. Data are representative of three independent experiments. Proliferation index 
was calculated from three independent experiments with three mice per experiment. (E and F) Egr2 (E) and Grail and Cbl-b (F) intracellular expression was 
determined and the MFI plotted for T cells specific for each epitope. Data in E are cumulative from two experiments with n = 3 or 4 mice per group. In F, 
one representative experiment is shown from two experiments with four mice. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (unpaired [A and B] or 
paired [D–F] Student’s t test); error bars represent mean ± SEM.
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Indeed, whereas FOXO1 is relatively high in memory precur-
sor cells (KLRG1loCD27hi), TBET is relatively low (Fig. 4 D).
Loss of Foxo1 prevents expression of the HMG-box 
transcription factor TCF7 (alias TCF-1; Hess Michelini et al., 
2013; Kim et al., 2013), a part of the canonical Wingless/In-
tegration 1 (Wnt) signaling pathway (Clevers, 2006) that has 
been shown to be essential for T cell memory in response 
to acute infection and persistent LCMV infections (Jeannet 
et al., 2010; Zhao et al., 2010; Zhou et al., 2010; Utzschnei-
der et al., 2016). In response to MCMV, it is also reexpressed 
by Fx1WT T cells, but not by Fx18KO T cells (Fig. 5 A). Fur-
thermore, because the T-box transcription factor EOM ES is 
Figure 4. Ag-specific Fx18Ko cd8+ t cells produce fewer memory precursors. (A) Spleen from Fx1WT and Fx18KO chimeras were harvested at 69 dpi, and 
tetramer+ cells were examined for the expression of KLRG1 and CD27. Graphs represent the quantification of the percentage of KLRG1low CD27+. Data are 
cumulative from three independent experiments with n = 2 to 4 mice per experiment and per group. (B) Histograms represent the percentage of KLRG1low 
CD27+ for each tetramer at day 8, 21, and 41 after infection. Data are cumulative from two to four experiments with minimum n = 3 mice per group and per 
time point. (c) Spleens from ID3-GFP reporter mice were harvested at day 100 after infection and the expression of ID3 was examined on KLRG1low CD27+ 
and KLRG1hi CD27− for each tetramer. Data are from one experiment with four mice. (d) Spleens from Fx1WT chimeras were harvested at 41 after infection 
and the expression of FOXO1 and TBET was examined on KLRG1low CD27+ and KLRG1hi CD27− cells for each tetramer. Data are from one experiment with 
five mice. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (unpaired [A and B] or paired [C and D] Student’s t test); error bars represent mean ± SEM.
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Figure 5. transcriptional control of McMV-specific t cells is altered in the absence of FoXo1. (A and B) TCF7 and EOM ES MFI were determined on 
CD8+ tetramer+ cells for IE3, M38, and M45 epitopes. FACS histograms show TCF7 (A) and EOM ES (B) MFI at 69 dpi. Quantification of EOM ES and TCF7 MFI at 
8, 41, and 69 dpi in the spleen of Fx1WT and Fx18KO chimeras. Data are from one experiment for day 8 with n = 4 mice per group and cumulative from three 
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downstream of TCF7, it too is not normally up-regulated in 
Fx18KO T cells (Fig. 5 B).
Antigen-inexperienced Fx18KO T cells (CD8+CD44lo) 
from MCMV-infected chimeras expressed an amount of 
TBET that was low but higher than that of Fx1WT T cells 
(Fig. 5 C). In addition, Ag-specific Fx18KO T cells expressed an 
increased amount of TBET compared with that of Fx1WT T 
cells (Fig. 5 D), yet they were defective in the antigen-induced 
expression of IFNγ (Fig. 5 E). However, these TBEThi T cells 
also exhibit characteristics of anergy, including the expression 
of EGR2 that interacts with TBET to diminish IFNγ tran-
scription (Singh et al., 2017). The loss of TCF7 and EOM ES 
and increase in TBET is consistent with a preferential effec-
tor-like phenotype of Fx18KO T cells as measured by the ex-
pression of GZMB over the course of the MCMV response 
(Fig. 5 F). Altogether, these data show that FOXO1 is needed 
for not only the induction of TCF7 and EOM ES but also 
the repression of TBET. FOXO1 appears to tightly regulate 
these transcription factors in both long-lived effector/mem-
ory CD8+ T cells and inflationary CD8+ T cells.
Foxo1 is continuously required to maintain McMV-specific 
memory t cell populations
To test the durability of the distinction between memory and 
effector cells, chimeras were infected, and after 30 d, Foxo1 
was deleted in CD8+ T cells by administration of tamoxifen. 
To clarify this model from the initial one, the chimeras are 
referred to as L.Fx1WT and L.Fx18KO chimeras (“L” meaning 
late). Groups of mice were analyzed at day 40 (5 d after dele-
tion) or day 56 (21 d after deletion; Fig. S4 A) for functional 
and transcriptional characteristics of memory and effector 
cells. These include the expression of BCL2, TCF7, EOM ES, 
and GZMB, as well as the phenotypic characteristics of mem-
ory and effector cells, KLRG1, and CD27.
The number of cells specific for all three epitopes was 
diminished with the late loss of FOXO1 with the exception 
of T cells specific for M38 at the early time point (Fig. 6 A). 
By day 56, there was also a marked reversal of the functional 
and transcriptional memory characteristics prominently re-
flected by the loss of BCL2 (Fig. 6 B), a characteristic that 
suggests this was not a selectively surviving T cell popula-
tion. In addition, there was a loss of TCF7 (Fig.  6  C and 
Fig. S4 B) and EOM ES (Fig. S4 C), as well as the gain of 
GZMB expression (Fig.  6 D and Fig. S4 D). Foxo1 dele-
tion also correlated with a skewing of the proportion of 
cells expressing KLRG1 and CD27 (Fig.  6  E and Fig. S4 
E). In addition to acquiring multiple phenotypic charac-
teristics of effector cells, the postinfection inactivation of 
Foxo1 also imbued the population with characteristics of 
anergy; that is, a loss of potential for cytokine production 
(Fig. 6 F) and a reduced binding of tetramers (Fig. 6 G and 
Figs. S4 F). To further characterize the effect of the late loss 
of FOXO1 on the CD8+ T cell response, we analyzed pe-
ripheral tissues and secondary lymphoid organs. After 21 d 
of FOXO1 inactivation, the MCMV-specific CD8+ T cell 
response was highly reduced in LNs, liver, lung, and blood 
(Fig. 7 A). This was accompanied by phenotypic changes for 
all three epitope-specific T cells, including reduced BCL2 
(Fig. 7 B) and TCF7 expression (Fig. 7 C) and an increase in 
GZMB (Fig. 7 D). Interestingly, the loss of memory precur-
sor KLRG1hi CD27+ was also found in peripheral organs of 
L.Fx18KO chimeras (Fig. 7 E). Finally, consistent with T cells 
found in the spleen, MCMV-specific CD8+ T cells displayed 
characteristics of anergy: loss of effector cytokine production 
(Fig. 7 F) and reduction of tetramer binding (Fig. 7 G).
To determine whether CD8+ T cells deleted for Foxo1 
are functionally responsive, we performed two types of adop-
tive transfer experiments. In the first, Fx1WT and Fx18KO 
chimeras were infected with MCMV for 21 d. The CD8+ 
CD44hi KLRG1hi CD27− and KLRG1low CD27+ cells were 
sorted (Fig. S5 A) and transferred into naive mice followed by 
MCMV infection to measure a secondary response. After 6 d, 
the memory and effector phenotype cells were enumerated 
(Fig. 8 A). As shown, CD27+ T cells displayed superior prolif-
erative capacity compared with CD27− T cells, and Foxo1WT 
T cells were capable of at least 10-fold more expansion as 
compared with Foxo18KO T cells. This applied to T cells that 
recognized all three epitopes (Fig. 8 B).
Finally, to determine whether FOXO1 is required for a 
recall response after the differentiation of effector and mem-
ory T cells, the Foxo1 gene was deleted 30 d after infection 
(Fig. S5 B) followed by an adoptive transfer (Fig. 8 C). With 
one exception, postinfection inactivation of Foxo1 caused T 
cells specific for all three epitopes to become severely dimin-
ished in their capacity for proliferation in a recall response 
measured 7 or 21 d after infection (Fig. 8 D). The exception 
was again the T cell subset–specific M38 at 7 d after a second-
ary infection (see Discussion). Collectively, these data suggest 
experiments for day 41 and day 69 with n = 2 to 5 mice per group and per experiment. (c) Fx1WT and Fx18KO splenocytes were harvested at the indicated 
time points after infection, and splenocytes were cultured for 5 h without peptide stimulation. FACS plots represent the frequency of IFNγ and TBET at 41 dpi 
gated on CD8+ CD44low. Quantification of TBET MFI on CD8+ CD44low was determined. Numbers represent the percentage of TBET+ IFNγ+ or TBET+ IFNγ−. Data 
are from one experiment with n = 3 mice per group. (d) Quantification of TBET MFI was examined ex vivo on CD8+ tetramer+ at 41 dpi. Data are from one 
experiment with n = 3 to 4 mice per group. (E) Fx1WT and Fx18KO splenocytes were harvested at different time points after infection and splenocytes stim-
ulated for 5 h with or without a specific peptide. FACS plots represent the frequency of IFNγ and TBET at 41 dpi gated on CD8+ CD44hi. Numbers represent 
the IFNγ MFI among the TBET+ IFNγ+ cells and the percentage of TBET+ IFNγ+ or TBET+ IFNγ−. Data are from one experiment with n = 3 to 4 mice per group. 
(F) Bivariant plots show the KLRG1 and GZMB expression at 41 dpi. Numbers represent the percentage of KLRG1+ GZMB+ and KLRG1− GZMB+. Graphs rep-
resent the GZMB MFI for the different time points and for each tetramer. Data are cumulative from two to four experiments with minimum n = 3 mice per 
group and per time point. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (unpaired Student’s t test [A–D and F]); error bars represent mean ± SEM.
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Figure 6. continued FoXo1 activity is crucial to maintain the survival and the differentiation state of McMV-specific cd8+ t cells. (A–G) 
Chimeras were treated with tamoxifen at day 30 after infection (Fig. S4 A) and analyzed either 5 or 21 d after inactivation of Foxo1. (A) Numbers of tetramer+ 
cells after 5 or 21 d of Foxo1 depletion. Data are cumulative from two experiments with n = 3 to 5 mice per group. (B) BCL2 expression for each tetramer 
and quantification is shown for one experiment representative of a total of two experiments with n = 3 to 5 mice per group. (C–G) Spleens were harvested 
21 d after inactivation of Foxo1. (C) TCF7 expression was determined and the MFI plotted for T cells specific for each epitope. (D) GZMB expression was 
determined and the MFI plotted for T cells specific for each epitope. (E) Tetramer+ T cells were examined for the expression of KLRG1 and CD27, and the 
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that FOXO1 has to be continuously present to maintain the 
full characteristics of Ag-specific CD8+ T cells after response 
to a persistent infection.
Inflation involves the FoXo1-dependent expression of tcF7
The immune response to CMV is unusual in the heterogene-
ity of responding T cells as illustrated by clonotypes specific 
for M45, M38, and IE3 epitopes. Nonetheless, all are depen-
dent on FOXO1 for full elaboration, and as shown here and 
previously, FOXO1 is essential for postactivation TCF7 ex-
pression, required for the maintenance of T cell memory. We 
therefore sought to determine how loss of TCF7 expression 
would affect T cell subsets specific for different epitopes. Spe-
cifically, we determined the relative segregation of the TCF7+ 
populations with respect to the expression of KLRG1.
As shown in Fig. 9 A, the Fx1WT T cells segregate as 
KLRG1hi TCF7− (typical of effector cells), KLRG1hi TCF7+, 
and KLRG1− TCF7+. With time, a majority of the Fx1WT 
KLRG1hi T cells become TCF7+, a correlation that suggests a 
role for TCF7 in inflationary T cell responses. This phenome-
non was also observed in the noninflationary M45-specific T 
cells (Fig. 9 A) and in an LCMV Armstrong infection (Del-
poux et al., 2017). The KLRG1hi TCF7+ cells express higher 
memory-associated molecules BCL2 and EOM ES and ex-
hibit diminished TBET expression compared with KLRG1hi 
TCF7− effector cells (Fig.  9  B). 5 d after inactivation of 
FOXO1, at the late stage of infection, we observed a dimin-
ished proportion of KLRG1hi TCF7+ and KLRG1− TCF7+ in 
the L.Fx18KO T cells specific for the three epitopes (Fig. 9 C). 
This diminution increased with the length of FOXO1 in-
activation, and it also occurred in T cells harvested from the 
lung (Fig. 9, C and D).
The population most strongly impacted by the dele-
tion of FOXO1 was characterized as KLRG1hi TCF7+. In 
an LCMV acute infection, KLRG1hi CD127+ T cells appear, 
and they have a longer half-life compared with terminally 
differentiated KLRG1hi CD127− effector CD8+ T cells (Cui 
and Kaech, 2010). This correlates with the observation that 
KLRG1hi CD127+ CD8+ T cells express higher amounts of 
TCF7 (Delpoux et al., 2017). Here, we show that the majority 
of KLRG1hi inflationary T cells express FOXO1-dependent, 
TCF7, and these cells increase with time. They may be 
a form of TEM cells that are capable of long-term survival 
and the continuous production of KLRG1+ effector cells. 
FOXO1 appears required for T cells to acquire and stabi-
lize the effector memory phenotype, but it is also necessary 
to maintain KLRG1hi TCF7+ MCMV-specific T cells as-
sociated with inflation.
dIscussIon
Herpesviruses are cospeciated with their vertebrate hosts, 
meaning the host-pathogen relationship has coevolved, in 
some cases for hundreds of millions of years (McGeoch and 
Gatherer, 2005; Wang et al., 2007). Herpesviruses are never 
cleared, and they are thus adapted to infect and remain en-
demic in most or all vertebrates regardless of population size 
or density. As herpes family infections have been inevitable for 
most of vertebrate evolution, they may have also provided an 
important selection pressure for the development of the adap-
tive immune system. In particular, they may have contributed 
to the evolution of memory T cells that are self-renewing and 
can be continuously or periodically activated to expand and 
manifest effector functions.
In humans and mice, cytomegaloviruses induce strong 
epitope-specific T cell responses that follow distinctly differ-
ent kinetics (Munks et al., 2006). At the extremes are T cells 
that rapidly expand and contract leaving behind typical cen-
tral memory T cells, and T cells that gradually and continually 
expand with phenotypic characteristics of memory-effector 
T cells (Klenerman and Oxenius, 2016; Smith et al., 2016). 
We were interested to know whether these two distinctly dif-
ferent forms of memory have a common pathway of differ-
entiation and maintenance.
The FOXO transcription factors are known to be im-
portant for cellular survival and organismal aging (Greer and 
Brunet, 2008; Martins et al., 2016). FOXO1 is essential for 
pluripotency for human and mouse embryonic stem cells, 
and it directly controls SOX2 and OCT4 expression, two of 
the four Yamanaka factors (Zhang et al., 2011; Takahashi and 
Yamanaka, 2016). It is also essential for the gene expression 
program associated with T cell memory as defined by the 
ability of T cells to be restimulated in a secondary response 
(Hess Michelini et al., 2013; Kim et al., 2013) or expand fully 
in a persistent viral infection (Staron et al., 2014).
Here, we show that T cells in which Foxo1 was deleted 
just before infection manifest a defective ability to accumu-
late that is caused by a deficiency in survival. T cell expan-
sion was uniformly diminished at all stages of the response, 
and remarkably, the absence of FOXO1 did not affect the 
unique profiles of expansion and contraction for each of the 
three different epitope-specific responses measured. This loss 
could not be attributed to a difference in progression through 
the cell cycle; rather, it primarily resulted from increased cell 
death as measured by cleaved caspase-3 and cell-surface An-
nexin V. Importantly, the surviving Foxo1-null T cells were 
low for BCL2 expression, an indication that this population 
was not rescued by differential expression of survival fac-
quantification of the percentage of KLRG1low CD27+ is shown. Numbers represent the percentage of KLRG1+ CD27−, KLRG1+ CD27+, and KLRG1− CD27+. 
(F) Total splenocytes were stimulated for 5 h with a specific peptide and the proportion of IFNγ and TNF gated on CD8+ CD44hi T cells are shown. Numbers 
represent the percentage of IFNγ+ TNF−, IFNγ+ TNF+, and IFNγ− TNF+ T cells. (G) Histograms represent the tetramer MFI plotted for T cells specific for each 
epitope. Data in C–G are cumulative from two experiment with n = 3 to 5 mice per group. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (unpaired 
Student’s t test [A–E and G]); error bars represent mean ± SEM.
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Figure 7. continued FoXo1 activity is crucial to maintain the survival and the differentiation state of McMV-specific cd8+ t cells in blood, 
lns, liver, and lungs. (A–G) Chimeras were treated with tamoxifen at day 30 after infection (Fig. S4 A) and analyzed 21 d after inactivation of Foxo1. 
(A) Numbers of tetramer+ cells in LNs, blood, liver, and lungs. Data are cumulative from two experiment with n = 4 mice per group. (B) BCL2 expression for 
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tors. The likelihood is that the entire Foxo1-null population 
lost expression of BCL2 as a consequence of transition from 
memory to effector T cells.
The present study also describes an important role for 
FOXO1 to prevent the induction of anergy in Ag-specific 
CD8+ T cells during a latent infection. One possibility is that 
the characteristics of anergy we noted (diminished tetramer 
avidity and calcium responses and enhanced ubiquitin ligases) 
in Foxo1-null T cells may also relate to the acquisition of an 
effector-like phenotype, especially under conditions of anti-
gen persistence. Previous work showed that compared with 
central memory T cells, effector-memory cells express higher 
amounts of KLRG1 and have reduced avidity for MHC–pep-
tide complexes due in part to an inhibitory signal delivered by 
KLRG1 (Griffiths et al., 2013). Still, the pathway involved in 
triggering the anergic state in Foxo1-null T cells is unknown.
The tendency to acquire an effector-like phenotype in 
the absence of FOXO1 was found to be continuously avail-
able to the antigen-specific responding T cells population. In-
activation of Foxo1 after MCMV infection had effects similar 
or identical to that of inactivation before infection. There was 
loss of BCL2, TCF7, EOM ES, and CD27, along with a gain 
of GZMB and KLRG1. These cells acquired an effector-like 
phenotype, but they were not capable effector cells because 
they were unable to produce a strong cytokine response. 
Either continued low-level antigen stimulation of effector 
cells causes a form of anergy or FOXO1 is required to main-
tain a full functional phenotype.
This raises the question of how FOXO1 is maintained 
as an active, nuclear, transcription factor in long-term mem-
ory cells. Comparing KLRG1+ and KLRG1− T cells after 
either LCMV (Hess Michelini et al., 2013) or CMV infection 
shows that the amount of FOXO1 expressed is greater in 
KLRG1−, effector-memory, or central memory T cells, and 
this level of regulation is possibly mediated by miR-150 (Ban 
et al., 2017). However, preliminary experiments show that the 
segregation of nuclear versus cytoplasmic FOXO1 in these 
subsets is equivalent (unpublished data). Although this sug-
gests that memory versus effector phenotypes are regulated 
by relatively small changes in overall expression, the myriad 
posttranslational modifications of FOXO transcription fac-
tors are also likely to influence its activity and transcriptional 
specificity (Zhao et al., 2011).
Surprisingly, we found Fx18KO M38 tetramer+ cells, 
uniquely, did not decrease in number 5 d after Foxo1 inac-
tivation and retained a proliferative capacity after secondary 
challenge. This may correlate with the fact the M38 Fx1WT T 
cells express less TCF7 and FOXO1 than IE3 CD8+ T cells 
(Figs. S4 B and S5 B); however, we do not understand the 
basis for a differential requirement for FOXO1 in IE3 and 
M38 T cells, and nothing is known regarding the sites or ki-
netics of M38 expression during MCMV infection in vivo 
that could provide insight. In summary, the present study re-
veals the profound requirements for FOXO1 in the diverse 
CMV-specific CD8+ T cell response, including survival, dif-
ferentiation, and function.
MAtErIAls And MEthods
Mice
C57BL/6 CD45.1 (CD45.1), C57BL/6 CD45.1/CD45.2 
(CD45.1/CD45.2), C57BL/6 CD8α−/−, and C57BL/6 
TCRα−/− (Tcra−/−) mice were bred in our colony at Univer-
sity of California, San Diego. Foxo1f/f mice were backcrossed 
to C57BL/6 (Jackson) for at least 13 generations and then 
crossed to Rosa26Cre-ERT2, which had also been backcrossed 
to C57BL/6 for at least 14 generations. Id3-GFP mice are 
congenic with C57BL/6 mice. Mice were maintained in a 
specific pathogen–free vivarium. All experiments were per-
formed in accordance to the Institutional Animal Care and 
Use Committee of University of California, San Diego.
Mixed bone marrow chimeras
Bone marrow cells were isolated from CD8α−/−, Foxo1f/f 
Rosa26Cre-ERT2+, Foxo1f/f Rosa26Cre-ERT2−, or CD45.1/CD45.2 
mice and processed under sterile conditions. A single-cell sus-
pension in PBS was obtained with a 1:1 ratio of CD8α−/− and 
Foxo1f/f Rosa26Cre-ERT2+ (Fx18KO chimera) or Foxo1f/f Rosa-
26Cre-ERT2- (Fx1WT chimera) bone marrow cells. 5 × 106 cells 
were injected i.v. into lethally irradiated (10 gray) TCRα−/− 
hosts in a volume of 200 µl. A second model of bone mar-
row transplantation was obtained by injecting a 1:1 ratio of 
CD45.1/CD45.2 and Foxo1f/f Rosa26Cre-ERT2+ (CD45.2) 
bone marrow cells into lethally irradiated (10 gray) C57BL/6 
CD45.1 hosts in a volume of 200 µl. Chimeras received auto-
claved water treated with antibiotics (trimethoprim-sulfame-
thoxazole) until 4 wk after injection.
tamoxifen treatment
After 8 wk of bone marrow transplantation, Fx18KO and 
Fx1WT chimeras were injected every day for 5 d with 200 µl 
each tetramer in LNs, liver, and lungs. Numbers represent the BCL2 MFI. Each FACS histogram is representative of two mice between two experiments with 
n = 4 mice per group and per experiment. (C) TCF7 expression was determined and the MFI plotted for T cells specific for each epitope in different organs. 
(D) GZMB expression was determined and the MFI plotted for T cells specific for each epitope in different organs. (E) Tetramer+ cells were examined for the 
expression of KLRG1 and CD27, and the quantification of the percentage of KLRG1low CD27+ T cells is shown. (F) Total lungs cells were stimulated for 5 h 
with a specific peptide and the proportion of IFNγ and TNF gated on CD8+ CD44hi T cells are shown. Numbers represent the percentage of IFNγ+ TNF−, IFNγ+ 
TNF+ and IFNγ− TNF+ T cells. (G) Histograms bars represent the tetramer MFI plotted for T cells specific for each epitope in the lungs. Data in A and C–G are 
cumulative from two experiments with n = 8 mice per group. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (unpaired Student’s t test [C–E and G]); 
error bars represent mean ± SEM.
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tamoxifen (Cayman Chemicals) diluted in seed oil at 10 
mg/ml. For late Foxo1 inactivation, tamoxifen treatment 
began 30 d after infection.
Viral infections and plaque assay
Salivary gland stocks of MCMV Δm157 (McWhorter et 
al., 2013) were derived from the bacterial artificial chro-
mosome–cloned MCMV strain K181 (Redwood et al., 
2005), as previously described (Lio et al., 2016). Fx18KO 
and Fx1WT chimeras were treated daily for 5 d with tamox-
ifen and after 5 d were infected with 5 × 105 PFU virus 
in 200 µl PBS i.p. At days 6, 8, 21, 41, 69, and 100 after 
infection, mice were killed by CO2 asphyxiation and or-
gans were harvested and immediately snap-frozen in liquid 
nitrogen. To determine viral titers, organs were weighed 
and homogenized, and serial dilutions of homogenates 
were added to monolayers of NIH-3T3 fibroblasts plated 
in 24-well plates. Plates were spun at 2,000 g for 10 min 
before incubation at 37°C, which increased the sensitiv-
ity of the plaque assays ∼6–10-fold. Cells were fixed with 
formalin, and plaques were visualized with 0.1% crystal 
violet and quantified.
cell suspensions
Spleen and peripheral LNs were homogenized and passed 
through a nylon cell strainer in HBSS (Gibco) supplemented 
with 2% FBS or in 5% FBS, 0.1% NaN3 (Sigma-Aldrich) 
in PBS for flow cytometry. Blood samples were obtained by 
facial vein puncture. Liver was harvested after perfusion with 
PBS. The tissue was homogenized, and cells were then re-
covered after Percoll separation. Lungs were harvested after 
intracardiac perfusion with PBS. Lungs were cut in small 
pieces then mechanically dissociated and digested with 1 mg/
ml collagenase D and 0.1 mg/ml DNase I (Roche) for 2 h 
at 37°C. The lungs were homogenized and passed through 
a nylon cell strainer in HBSS 2% FBS media. An ACK lysis 
buffer was applied on all cell suspensions and were resus-
pended in HBSS 2% FBS media.
Fluorescence staining and flow cytometry
Cell suspensions were collected and dispensed into 96-well 
round-bottom microtiter plates (4 × 106 cells/well). Surface 
staining was performed as previously describe. In brief, cells 
were incubated on ice (for 15 min per step) with Abs in 5% 
FCS, 0.1% NaN3 (Sigma-Aldrich) PBS. Each cell-staining re-
action was preceded by a 15-min incubation with a purified 
anti–mouse CD16/32 Ab (FcγRII/III block; 2.4G2). We used 
antibodies specific for CD4, CD8, CD11a, CD11b, CD11c, 
CD27, CD44, CTLA-4, Egr2, EOM ES, FOXP3, KLRG1, 
LAG-3, PD-1, TCRβ, and Tim-3 from eBioscience. Rab-
bit anti–mouse TCF7 and FOXO1 (directly conjugated or 
not) and NFAT1 antibodies were from Cell Signaling. BCL2, 
PE-labeled GZMB, and FITC-Ki-67 antibodies are from 
BD Biosciences. APC-labeled GZMB was from Invitrogen. 
NFAT2, TBET, and XCRI antibodies were from BioLegend. 
For E3 ubiquitin ligase staining, we used goat anti–Cbl-b (sc-
1435) and rabbit anti-AIP4 (ITCH; sc-25625) from Santa 
Cruz Biotechnology and rabbit anti-RNF128 (Grail) from 
Abcam (ab137088). Secondary Alexa Fluor 647 donkey anti- 
rabbit (Invitrogen) was used to reveal FOXO1, Grail, ITCH, 
or TCF7 staining and secondary FITC donkey anti-goat (sc-
2024) from Santa Cruz Biotechnology was used to reveal 
Cbl-b staining. For intracellular staining, the FOXP3 Staining 
Buffer Set (eBioscience) was used. BV421-labeled IE3, M38, 
and M45 tetramers were made and provided by National In-
stitutes of Health tetramer core facilities (Atlanta, GA). Multi-
color immunofluorescence was analyzed using a BD Fortessa 
and BD Fortessa X-20 cytometer (BD Biosciences). List-
mode data files were analyzed using FlowJo Software.
Adoptive transfers and cell sorting
Splenocytes were harvested from Fx1WT and Fx18KO chimeras 
or from L.Fx1WT and L.Fx18KO chimeras. Total CD8+ cells 
were enriched by negative selection with an EasySep Mouse 
CD8+ T Cell Isolation kit (STE MCE LL Technologies). Cells 
were stained with antibodies against CD8, CD27, CD44, and 
KLRG1, and a fraction of each sample was analyzed for the 
percentage of tetramer for IE3, M38, and M45 epitope. The 
CD8+ CD44hi KLRG1hi CD27− and KLRG1low CD27+ cells 
were sorted on ARIA Fusion (BD Biosciences). Sort pu-
rity was checked on a BD Fortessa X-20. Sorted cells were 
counted, and 105 cells were transferred. The number of trans-
ferred tetramer-binding CD8+ T cells was estimated using the 
tetramer frequency within the enriched CD8+ population 
and the postsort purity analysis. Fold expansion was calcu-
lated as the number of tetramer-binding T cells in the spleen 
at various times after challenge over the total number of 
tetramer+ cells transferred (assuming 10% engraftment).
calcium measurement
2.5 × 106 splenocytes were resuspended in HBSS (phenol red 
free) with 1% FBS and 1 mM Ca2+ and Mg2+ plus 10 mM 
Hepes. Cells were loaded both Fluo-4 (Invitrogen) and Fura- 
Red (Invitrogen) mix dye for 45 min at 37°C. Cells were 
washed twice and stained for surface markers, and purified 
anti-CD3ε (clone 145-2C11; eBioscience) was added to the 
Figure 8. cd8+ KlrG1low cd27+ Fx18Ko fail to make a secondary response after inactivation of FoXo1. (A) Model depicting the strategy used 
to measure a secondary response. (B) Fold expansion of CD8+ tetramer+ was determined 6 d after challenge. Data are cumulative from two transfer ex-
periments with n = 3 or 4 mice per group and per experiment. (c) Model representing the secondary response after inactivation of Foxo1 at day 30 after 
infection. (d) Fold expansion of CD8+ tetramer+ at day 7 and day 21 after challenge. Data are cumulative from two transfers experiment with n = 3 or 4 mice 
per group and per experiment. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (unpaired Student’s t test [B and D]); error bars represent mean ± SEM.
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mix of antibodies. Samples were run at low speed, and pu-
rified anti-hamster was added to activate the cells after 30 s 
of acquisition on the Fortessa X-20 cytometer. Curves show 
ratio of Fluo-4 mean fluorescence intensity (MFI) and Fura- 
Red MFI over the time. The curves represent the CD8+ 
CD44hi CD11ahi T cells gated on CD45.1+ CD45.2+ dou-
ble-positive and CD45.2+ CD45.1− for Foxo1 WT and 
Foxo1-null cells, respectively.
Figure 9. FoXo1 maintains KlrG1+ tcF7+ effector-memory McMV-cd8+ t cells. (A–c) Fx1WT and Fx18KO splenocytes were harvested at 
indicated time points after infection. (A) Bivariant analysis of KLRG1 and TCF7 at 8 and 69 dpi gated on tetramer+ cells (left) and each population 
were graphed for each time point (right) in Fx1WT chimeras. Data are from one experiment for day 8 with n = 4 mice per group and cumulative from 
two experiments for day 21 and three experiments for day 41 and 69 with n = 2–5 mice per group and per experiment. (B) Numbers represent the 
percentage of KLRG1+ TCF7−, KLRG1+ TCF7+ and KLRG1− TCF7+. EOM ES, BCL2 and TBET expression is shown for each population and each tetramer 
at day 41 after infection in Fx1WT chimeras. Numbers indicate the MFI of each molecule for each subset. (c and d) Chimeras were treated with 
tamoxifen at day 30 after infection and splenocytes were analyzed either 5 or 21 d after inactivation of Foxo1. Histograms show the proportion of 
the indicated population for each tetramer in the spleen (C) and lung (D) of L.Fx1WT and L.Fx18KO chimeras. Data are cumulative from two experiments 
for each time point with n = 8–9 mice per group. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (unpaired Student’s t test [C and D]); error 
bars represent mean ± SEM.
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cytokine detection
To asses intracellular cytokine production, 2 × 106 spleno-
cytes or lung cells were unstimulated or stimulated with 1 
µg/ml IE3, M38, or M45 peptide and 10 µg/ml Monensin 
(eBioscience) for 5  h at 37°C. Cells were then stained for 
surface markers. Foxp3 Staining Buffer Set (eBioscience) was 
used for fixation and permeabilization, followed by labeling 
with specific cytokine Abs for IFNγ (clone XMG1.2) and 
TNF (clone MP6-XT22) from eBioscience.
tetramer decay assay
The avidity of T cell populations was evaluated by decay 
of tetramer binding, as previously described (Wang and 
Altman, 2003). Splenocytes were harvested at day 41 after 
infection from Fx18KO and Fx1WT chimeras. 4 × 106 spleno-
cytes were stained with M38 tetramer for 30 min at 4°C in 
the presence of anti-CD8 mAb and anti-CD4 mAb. After 
three washes, anti-H-2Kb (clone Y-3) from BioXCell was 
added to a final concentration of 10  µM, and cells were 
removed at various time points and immediately fixed in 
2% paraformaldehyde/PBS.
Proliferation assay
CD8+ T cells were purified from spleen cells with STE M 
CE LL total CD8+ isolation kit as manufacturer’s instruc-
tions. Cells were stained with 0.5  µM CFSE for 10 min 
at 37°C. Adding equal volume of FBS stopped the reac-
tion. Cells were washed twice then counted. 0.2 × 106 cells 
per well were activated for 3 d at 37°C in 96-well plates 
previously coated with anti-CD3/anti-CD28. Prolifera-
tion index = log2 (f), where f = CFSE MFI (in the absence 
of stimulation)/CFSE MFI (in the presence of stimula-
tion; Delpoux et al., 2012).
Apoptosis assay
For active caspase-3 detection, the CaspGlow Fluorescein 
Caspase-3 Staining kit (eBioscience) was used according 
to the manufacturer’s instructions. In brief, cells from the 
spleen, LNs, and lung were stained for surface markers as 
described in the Fluorescence staining and flow cytometry 
section and cultured at 2 × 106 cells per well in complete 
media. 1 µl FITC-DEVD-FMK was added in 300 µl cells. 
Cells were washed twice and samples were acquired on cy-
tometer. For some experiments, apoptosis was evaluated via 
flow cytometry using fluorescently conjugated Annexin V 
(BD Pharmingen). Upon the completion of surface stain-
ing, the splenocytes were washed and incubated in Annexin 
V binding buffer with Annexin V at a 1:20 dilution for 15 
min at room temperature. The cells were then washed, re-
suspended in Annexin V binding buffer, and analyzed by 
flow cytometry immediately.
statistical analysis
Prism 6 software (GraphPad) was used to analyze data by 
two-tailed unpaired or paired Student's t test (*, P < 0.05; 
**, P < 0.01; ***, P < 0.001; ****, P < 0.0001). Data are 
presented as means ± SEM.
online supplemental material
Fig. S1 shows that only the CD8+ T cell response is altered in 
Fx18KO mice and shows the FOXO1 deletion efficiency at day 
8 and 69 after infection. Fig. S2 shows the increase apoptosis 
of MCMV-specific CD8+ T cells in the liver, LNs, and lungs 
of Fx18KO mice. Fig. S3 shows that MCMV-specific CD8+ T 
cells are not exhausted but display anergic phenotype. Fig. S4 
depicts the model of late deletion of FOXO1 and the phe-
notype of MCMV-specific CD8+ T cells after 5 d of deletion. 
Fig. S5 depicts the sorting strategy and the FOXO1 deletion 
efficiency after 5 d of the last tamoxifen treatment.
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